Literature DB >> 30936326

Rectal adenocarcinoma with rectoprostatic fistula following prostate brachytherapy.

Basil Francis Moss1, Amjad M Peracha1.   

Abstract

An 80-year-old man with history of prostate cancer successfully treated with brachytherapy was initially thought to have Fournier's gangrene until imaging detected a rectoprostatic fistula. Although this is known to be a rare complication of prostate brachytherapy, in this case the aetiology was a new primary rectal adenocarcinoma. It was not possible to catheterise per urethra owing to the fistula, so he was fitted with suprapubic catheter, and underwent palliative loop colostomy. Brachytherapy carries a low risk of second primary cancers, although two previous cases reported such cancers as radiation induced. This is, to our knowledge, the first case of rectal adenocarcinoma following prostate brachytherapy in the literature. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  catheterisation / catheter care; colon cancer; general surgery; prostate; radiotherapy

Mesh:

Year:  2019        PMID: 30936326      PMCID: PMC6453393          DOI: 10.1136/bcr-2018-226151

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  16 in total

1.  Emergency presentation of colorectal cancer is associated with poor 5-year survival.

Authors:  C S McArdle; D J Hole
Journal:  Br J Surg       Date:  2004-05       Impact factor: 6.939

2.  Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.

Authors:  Alan M Nieder; Michael P Porter; Mark S Soloway
Journal:  J Urol       Date:  2008-09-17       Impact factor: 7.450

3.  Risk of second cancers according to radiation therapy technique and modality in prostate cancer survivors.

Authors:  Amy Berrington de Gonzalez; Jeannette Wong; Ruth Kleinerman; Clara Kim; Lindsay Morton; Justin E Bekelman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-02-01       Impact factor: 7.038

4.  Second primary cancers occurring after I-125 brachytherapy as monotherapy for early prostate cancer.

Authors:  H Musunuru; M Mason; L Murray; B Al-Qaisieh; P Bownes; J Smith; K Franks; B Carey; D Bottomley; A M Henry
Journal:  Clin Oncol (R Coll Radiol)       Date:  2014-02-06       Impact factor: 4.126

5.  Clinical course of rectal bleeding following I-125 prostate brachytherapy.

Authors:  K Hu; K Wallner
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-05-01       Impact factor: 7.038

6.  Prostatourethral-rectal fistula after prostate brachytherapy.

Authors:  D Theodorescu; J Y Gillenwater; P G Koutrouvelis
Journal:  Cancer       Date:  2000-11-15       Impact factor: 6.860

7.  Prostate brachytherapy and second primary cancer risk: a competitive risk analysis.

Authors:  Karel A Hinnen; Michael Schaapveld; Marco van Vulpen; Jan J Battermann; Henk van der Poel; Inge M van Oort; Joep G H van Roermund; Evelyn M Monninkhof
Journal:  J Clin Oncol       Date:  2011-10-24       Impact factor: 44.544

8.  A contemporary analysis of Fournier gangrene using the National Surgical Quality Improvement Program.

Authors:  Stanley Y Kim; James M Dupree; Brian V Le; Dae Y Kim; Lee C Zhao; Shilajit D Kundu
Journal:  Urology       Date:  2015-03-11       Impact factor: 2.649

9.  Rectal complications after prostate brachytherapy.

Authors:  Shimul A Shah; Robert R Cima; Eric Benoit; Elizabeth L Breen; Ronald Bleday
Journal:  Dis Colon Rectum       Date:  2004-08-12       Impact factor: 4.585

10.  Contemporary Trends in the Inpatient Management of Fournier's Gangrene: Predictors of Length of Stay and Mortality Based on Population-based Sample.

Authors:  James Furr; Tanya Watts; Ryan Street; Brian Cross; Gennady Slobodov; Sanjay Patel
Journal:  Urology       Date:  2016-09-28       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.